PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY

被引：0

作者：

Baldini, Capucine ^{[1
]}

Cassier, Philippe A. ^{[2
]}

Delord, Jean-Pierre ^{[3
]}

Simonelli, Matteo ^{[4
]}

Touat, Mehdi ^{[5
]}

Yao, Lili ^{[6
]}

Duic, J. Paul ^{[6
]}

Gozman, Alexander ^{[6
]}

Marabelle, Aurelien ^{[7
,8
]}

机构：

[1] Univ Paris Saclay, Drug Dev Dept DITEP, Gustave Roussy, Villejuif, France

[2] Ctr Leon Berard, Dept Med Oncol, Lyon, France

[3] Inst Claudius Regaud IUCT Oncopole, Toulouse, France

[4] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Italy

[5] Humanitas Res Hosp, IRCCS, Rozzano, Italy

[6] Sorbonne Univ, AP HP, Univ Pitie Salpetriere Charles Foix,CNRS, Inst Cerveau,ICM,Serv Neurol, 2 Mazarin, F-75013 Paris, France

[7] Merck Co Inc, Rahway, NJ USA

[8] Univ Paris Saclay, Inst Natl Sante & Rech Med, Dept Innovat Therapeut & Essais Precoces, Gustave Roussy,U1015 CIC1428, Villejuif, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CTIM-03

引用

页码：59 / 60

页数：2